These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6722933)

  • 1. Drug residue formation from ronidazole, a 5-nitroimidazole. V. Cysteine adducts formed upon reduction of ronidazole by dithionite or rat liver enzymes in the presence of cysteine.
    Wislocki PG; Bagan ES; Vandenheuvel WJ; Walker RW; Alvaro RF; Arison BH; Lu AY; Wolf FJ
    Chem Biol Interact; 1984 Apr; 49(1-2):13-25. PubMed ID: 6722933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug residue formation from ronidazole, a 5-nitroimidazole. VI. Lack of mutagenic activity of reduced metabolites and derivatives of ronidazole.
    Wislocki PG; Bagan ES; Cook MM; Bradley MO; Wolf FJ; Lu AY
    Chem Biol Interact; 1984 Apr; 49(1-2):27-38. PubMed ID: 6722938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of reductive activation of a 5-nitroimidazole by flavoproteins: model studies with dithionite.
    Kedderis GL; Argenbright LS; Miwa GT
    Arch Biochem Biophys; 1988 Apr; 262(1):40-8. PubMed ID: 3128179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug residue formation from ronidazole, a 5-nitroimidazole. III. Studies on the mechanism of protein alkylation in vitro.
    Miwa GT; West SB; Walsh JS; Wolf FJ; Lu AY
    Chem Biol Interact; 1982 Sep; 41(3):297-312. PubMed ID: 6809347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug residue formation from ronidazole, a 5-nitroimidazole. I. Characterization of in vitro protein alkylation.
    West SB; Wislocki PG; Fiorentini KM; Alvaro R; Wolf FJ; Lu AY
    Chem Biol Interact; 1982 Sep; 41(3):265-79. PubMed ID: 6809345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent interaction of 5-nitroimidazoles with DNA and protein in vitro: mechanism of reductive activation.
    Kedderis GL; Argenbright LS; Miwa GT
    Chem Res Toxicol; 1989; 2(3):146-9. PubMed ID: 2519718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug residue formation from ronidazole, a 5-nitroimidazole. II. Involvement of microsomal NADPH-cytochrome P-450 reductase in protein alkylation in vitro.
    West SB; Wislocki PG; Wolf FJ; Lu AY
    Chem Biol Interact; 1982 Sep; 41(3):281-96. PubMed ID: 6809346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic activation of ronidazole [(1-methyl-5-nitroimidazole-2-yl)-methyl carbamate] to reactive metabolites by mammalian, cecal bacterial and T. foetus enzymes.
    Miwa GT; Wang R; Alvaro R; Walsh JS; Lu AY
    Biochem Pharmacol; 1986 Jan; 35(1):33-6. PubMed ID: 3940524
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug residue formation from ronidazole, a 5-nitroimidazole. VII. Comparison of protein-bound products formed in vitro and in vivo.
    Miwa GT; Alvaro RF; Walsh JS; Wang R; Lu AY
    Chem Biol Interact; 1984 Jul; 50(2):189-202. PubMed ID: 6744464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of activation and the mutagenicity of ronidazole, a 5-nitroimidazole.
    Miwa GT; Wislocki P; Bagan E; Wang R; Walsh JS; Lu AY
    Adv Exp Med Biol; 1986; 197():527-35. PubMed ID: 3766278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug residue formation from ronidazole, a 5-nitro-imidazole. IV. The role of the microflora.
    Wolf FJ; Alvaro RF; Fiorentini K; Green M; Lu AY; Miwa GT; Wislocki PG; Koch RT; McLafferty MA; Goldman P
    Chem Biol Interact; 1983 Jul; 45(1):7-14. PubMed ID: 6872101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reductive metabolism of metronidazole and ronidazole by aerobic liver microsomes.
    Perez-Reyes E; Kalyanaraman B; Mason RP
    Mol Pharmacol; 1980 Mar; 17(2):239-44. PubMed ID: 6248760
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug residue formation from ronidazole, a 5-nitroimidazole. VIII. Identification of the 2-methylene position as a site of protein alkylation.
    Alvaro RF; Wislocki PG; Miwa GT; Lu AY
    Chem Biol Interact; 1992 Mar; 82(1):21-30. PubMed ID: 1547514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of metabolic activation of ronidazole, a 5-nitroimidazole.
    Lu AY; Wislocki PG; Bagan ES; Wang RW; Walsh JS; Miwa GT
    Biochem Soc Trans; 1984 Feb; 12(1):7-9. PubMed ID: 6705992
    [No Abstract]   [Full Text] [Related]  

  • 15. Kinetic studies on reduction of cytochromes P-450 and b5 by dithionite.
    Davydov DR; Karyakin AV; Binas B; Kurganov BI; Archakov AI
    Eur J Biochem; 1985 Jul; 150(1):155-9. PubMed ID: 4018075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatographic and spectroscopic characterization of sulphur-bound dimetridazole and ranidazole derivatives.
    Girard M; Carignan G; Mousseau N; Dawson BA
    J Pharm Biomed Anal; 1991; 9(2):151-7. PubMed ID: 1873306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-catalysed, O2-independent inactivation of NADPH- or dithionite-reduced microsomal cytochrome P-450 by carbon tetrachloride.
    de Groot H; Haas W
    Biochem Pharmacol; 1981 Aug; 30(16):2343-7. PubMed ID: 7295345
    [No Abstract]   [Full Text] [Related]  

  • 18. Microsomal metabolism of the 5-lipoxygenase inhibitors L-746,530 and L-739,010 to reactive intermediates that covalently bind to protein: the role of the 6,8-dioxabicyclo[3.2.1]octanyl moiety.
    Chauret N; Nicoll-Griffith D; Friesen R; Li C; Trimble L; Dubé D; Fortin R; Girard Y; Yergey J
    Drug Metab Dispos; 1995 Dec; 23(12):1325-34. PubMed ID: 8689939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of ronidazole by swine. 1. Radiocarbon content of tissues.
    Wolf FJ; Baylis FP; Smith GE; Rosenblum C; Meriwether HT; Alvaro RF; Wolf DE; Koniuszy FR; Jacob TA
    J Agric Food Chem; 1983; 31(3):559-64. PubMed ID: 6886210
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of a cysteinyl adduct of oxidized 3-methylindole from goat lung and human liver microsomal proteins.
    Ruangyuttikarn W; Skiles GL; Yost GS
    Chem Res Toxicol; 1992; 5(5):713-9. PubMed ID: 1446013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.